Isolated severe tricuspid regurgitation is associated with larger dimensions of the superior and inferior venae cavae at various levels, a new study shows. What are the implications for transcatheter tricuspid valve intervention?
In Isolated Tricuspid Regurgitation, CMR and TTE Play Key Complementary Roles
In isolated TR, adding cardiac MRI to echocardiography and clinical assessment can help identify which patients have severe valve regurgitation and are most apt to have a poor outcome, a new study shows.
Transcatheter Valved Stent Tames Tricuspid Regurgitation in High-Risk Patients
The investigational GATE tricuspid valved stent is the first transcatheter prosthesis to be placed directly at the tricuspid annulus in humans. Our specialists who performed the first case discuss the technology’s evolution.
Distinctive Dozen: 12 Developments from 2016 Likely to Reshape Cardiovascular Practice
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
First Implant of a Transcatheter Tricuspid Valved Stent Marks New Frontier in Percutaneous Valve Care
A Cleveland Clinic team successfully completed the world’s first transcatheter tricuspid valve replacement in November 2016, raising hopes for a minimally invasive option for severe tricuspid regurgitation.